Common Stock
- Symbol
- SSII
- Exchange
- NASDAQ
- Classification
- COMMON
Current Report · Items 7.01, 9.01 · 8-K
SS Innovations International Inc.
SSIINASDAQEQUITYCurrent
Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. Included with this Current Report as Exhibit 99.1 is an updated October 2026 Company Presentation (the “Company Presentation”), which SSi intends to use in communications to shareholders and the investment community.…
Company context
We are a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. We design, manufacture and market an advanced, next-generation and affordable surgical robotic system called the SSi Mantra Surgical Robotic System (the “SSi Mantra”) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic and cardiac surgeries. While surgical robotic systems have gained acceptance globally in the past two decades for providing greater efficiency, better clinical outcomes and reducing healthcare costs, access to such systems remains largely limited to developed countries such as the United States (the “U.S.”), the European Union (the “EU”) and Japan. With the SSi Mantra, we are breaking down barriers and accelerating access to surgical robotics technologies in underserved regions of the world.
Current securities
Registered securities in this filing
SS INNOVATIONS INTERNATIONAL, INC. · 8-K · Filed 2026-10-05
Disclosure sections
Item 7.01Item 7.01 - Regulation FD Disclosure
Item
7.01 Regulation FD Disclosure.
Included
with this Current Report as Exhibit 99.1 is an updated October 2026 Company Presentation (the “Company Presentation”),
which SSi intends to use in communications to shareholders and the investment community.
The
information set forth in Item 7.01 of this Current Report and in the Company Presentation included as Exhibit 99.1 to this
Current Report, are deemed to be “furnished” and shall not be deemed to be “filed” for purposes of Section 18
of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or otherwise subject to the liabilities of
that Section. The information set forth in Item 7.01 of this Current Report and in the Company Presentation included as Exhibit
99.1 to this Current Report, shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities
Act of 1933, as amended, regardless of any general incorporation language in such filing.
Forward-Looking
Statements
This
Current Report and the Company Presentation included as Exhibit 99.1 to this Current Report that are not historical facts and
are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements
include all statements that are not historical statements of fact and statements regarding the Company’s intent, belief or expectations,
including, but not limited to, product development, clinical and regulatory timelines, market opportunity, competitive position, possible
or assumed future results of operations and other statement that are predictive in nature. The words “anticipate,” “assume,”
“believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,”
“project,” “should,” “could,” “seek,” “designed,” “potential,”
“forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar
expressions to identify such forward-looking statements. These statements relate to future events or SSi’s future financial performance
and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance,
or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied
by these forward-looking statements. You should not place undue reliance on forward-looking statements.
Filed exhibits (1)
Exhibit 99.1 We Build Advanced, Affordable and Accessible Surgical Robotic Solutions SS Innovations International, Inc. Company Presentation October 2026 Nasdaq: SSII © 2026 SS INNOVATIONS INTERNATIONAL, INC. 2 No Offering of Securities No offer is made by this Company Presentation (this "Presentation") to invest in SS Innovations International, Inc. (the "Company") or to purchase any of its securities. Any offer to make such an investment or purchase and such investment or purchase will be made only pursuant to definitive offering documentation furnished by the Company. Forward-Looking Statements This Presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by our forward-looking statements. Examples of forward-looking statements include statements regarding the benefits, uses and…
Open exhibit ↗